Transfer-pricing treatment of ITeS margins excludes pass-through tax recoveries and separate delayed-receivables interest after working-capital adjust...
Capacity-utilisation adjustments under TNMM can neutralise substantiated COVID-related idle costs where underutilisation materially affects profitabil...
TNMM functional comparability requires excluding rice manufacturers from a pure Basmati rice trader's benchmark and recognising operating export recei...
Working-capital adjustment subsumes delayed-receivable effects in TNMM benchmarking of captive software-development services, avoiding separate notion...
Transfer-pricing comparability requires exclusion of financially illogical super-profit comparables and correction of unsupported annual-report and ma...
Charitable character assessment preserves Section 80G approval despite inclusive spiritual teachings and incidental religious expenditure within the s...
Penalty proceedings for cash-loan acceptance require assessment proceedings and recorded Assessing Officer satisfaction; absent these, the proceedings...
Page of 4828
Press 'Enter' after typing page number.
161 to 180 of 96556 Results
❮
❯
❯❯
0 / 200
Expand Note
Add to Folder
No Folders have been created
+
Are you sure you want to delete "My most important" ?
The assessee, incorporated under Canadian laws, rendered pre-clinical laboratory services to Indian customers in the pharmaceutical, medical device, and biotechnology industries. These services involved conducting in vitro and in vivo tests and trials to determine safe dosages and assess potential toxicity of new drugs before human clinical trials. The Indian customers provided samples for testing by the assessee. The Tribunal held that the pre-clinical laboratory services rendered by the assessee did not constitute "making available" technical knowledge, experience, skill, know-how, or processes to the Indian customers. The utility of the services was limited to a report, which did not independently transfer technological knowledge enabling the clients to conduct future clinical tests. The clients had to continuously refer to the assessee for understanding the report. Therefore, the receipts from such services did not qualify as Fees for Included Services (FIS) or Fees for Technical Services (FTS) under the India-Canada Tax Treaty.
The assessee, incorporated under Canadian laws, rendered pre-clinical laboratory services to Indian customers in the pharmaceutical, medical device, and biotechnology industries. These services involved conducting in vitro and in vivo tests and trials to determine safe dosages and assess potential toxicity of new drugs before human clinical trials. The Indian customers provided samples for testing by the assessee. The Tribunal held that the pre-clinical laboratory services rendered by the assessee did not constitute "making available" technical knowledge, experience, skill, know-how, or processes to the Indian customers. The utility of the services was limited to a report, which did not independently transfer technological knowledge enabling the clients to conduct future clinical tests. The clients had to continuously refer to the assessee for understanding the report. Therefore, the receipts from such services did not qualify as Fees for Included Services (FIS) or Fees for Technical Services (FTS) under the India-Canada Tax Treaty.
Note: It is a system-generated summary and is for quick reference only.